Xos (XOS) director gets 1,200 RSUs for Q4 committee chair retainer
Rhea-AI Filing Summary
Xos director Alice Yake received 1,200 shares of common stock on January 10, 2026 as stock-based board compensation. These shares came from restricted stock units granted in lieu of the cash retainer for her service as Nominating and Corporate Governance Committee Chair for the fourth quarter of 2025, and the RSUs vested immediately on the grant date.
After this grant, she beneficially owned 104,685 shares of Xos common stock, including 62,377 unvested RSUs. The transaction was recorded at a price of $0 per share, reflecting that it was an equity award rather than an open-market purchase.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Xos (XOS) disclose for January 10, 2026?
Xos reported that director Alice Yake received 1,200 shares of common stock on January 10, 2026, issued through restricted stock units as part of her board compensation.
Why did Xos director Alice Yake receive 1,200 RSUs instead of cash?
The 1,200 RSUs were granted to Alice Yake in lieu of the cash retainer for her service as Nominating and Corporate Governance Committee Chair during the fourth quarter of 2025.
When did the RSUs granted to the Xos director vest?
The filing states that the restricted stock units granted to Alice Yake vested immediately on the January 10, 2026 grant date.
How many Xos shares does Alice Yake beneficially own after this transaction?
Following the award, Alice Yake beneficially owned 104,685 shares of Xos common stock, which the disclosure notes includes 62,377 unvested RSUs.
Was the Xos insider transaction an open-market purchase or a grant?
The transaction is coded as an “A” (acquisition) at a reported price of $0 per share, indicating it was a rather than an open-market purchase.
What role does the Xos director hold that relates to this RSU award?
The restricted stock units were issued to compensate Alice Yake for serving as Nominating and Corporate Governance Committee Chair for Xos in the fourth quarter of 2025.